MJ, R., HC, H., DJ, M., JC, B., L, D., PM, D., . . . Martin, J. L. (2003). Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: Results from the TARGET trial. Journal of the American College of Cardiology (JACC), 42(6), 981. https://doi.org/10.1016/s0735-1097(03)00913-6
Chicago Style (17th ed.) CitationMJ, Ross, et al. "Angiographic Variables Predict Increased Risk for Adverse Ischemic Events After Coronary Stenting with Glycoprotein IIb/IIIa Inhibition: Results from the TARGET Trial." Journal of the American College of Cardiology (JACC) 42, no. 6 (2003): 981. https://doi.org/10.1016/s0735-1097(03)00913-6.
MLA (9th ed.) CitationMJ, Ross, et al. "Angiographic Variables Predict Increased Risk for Adverse Ischemic Events After Coronary Stenting with Glycoprotein IIb/IIIa Inhibition: Results from the TARGET Trial." Journal of the American College of Cardiology (JACC), vol. 42, no. 6, 2003, p. 981, https://doi.org/10.1016/s0735-1097(03)00913-6.